Home > Financial Ratios > GLAND PHARMA
AD     Remove this Ad

GLAND PHARMA Last 5 Year Sales/Fixed Asset History

[Consolidated]

Mar2025Mar2024Mar2023Mar2022Mar2021
   Sales/Fixed Asset(x) 1.061.551.662.512.49

What is the latest Sales/Fixed Asset ratio of GLAND PHARMA ?

The latest Sales/Fixed Asset ratio of GLAND PHARMA is 1.06 based on Mar2025 Consolidated results.
Year Sales/Fixed Asset
Mar20251.06
Mar20241.55
Mar20231.66
Mar20222.51
Mar20212.49

How is Sales/Fixed Asset of GLAND PHARMA Trending?

Years Sales/Fixed Asset % Change
Mar2025 1.06
-31.61
Mar2024 1.55
-6.63
Mar2023 1.66
-33.86
Mar2022 2.51
0.80
Mar2021 2.49 -

Other Financial Ratios of GLAND PHARMA


Compare Sales/Fixed Asset ratio of peers of GLAND PHARMA

Peers & Returns Market Capitalization 1 Week 1 Month 1 Year
GLAND PHARMA ₹28,672.7 Cr 2.3% 3.6% 11.8% Stock Analytics
SUN PHARMACEUTICAL INDUSTRIES ₹397,018.0 Cr -2.3% -8.5% -3% Stock Analytics
DIVIS LABORATORIES ₹162,454.0 Cr 5.3% -3.4% 3.4% Stock Analytics
TORRENT PHARMACEUTICALS ₹140,702.0 Cr 3.7% -4.9% 26% Stock Analytics
DR REDDYS LABORATORIES ₹102,830.0 Cr 1.2% -4.2% 5.3% Stock Analytics
CIPLA ₹99,325.0 Cr 2.4% -7.2% -18.1% Stock Analytics


GLAND PHARMA Share Price vs Sensex


Share Price Returns(%) 1 Week 1 Month 1 Year
GLAND PHARMA

2.3%

3.6%

11.8%

SENSEX

5.8%

-1.7%

1.2%


You may also like the below Video Courses